Meniere's disease (Meniere's disease) is a disease of the inner ear, characterized by attacks of vertigo, hearing loss and phantom sounds (tinnitus, "ringing in the ears"). If these three symptoms occur together, we speak of the Triassic of Menière. The causes of Meniere's disease are unknown. There are some methods of treatment that can favorably influence the course of the disease, but sometimes they are controversial.
The disease usually occurs between the 40th and the 60th year of life and affects women slightly more often than men.
The name dates back to the French ear specialist Prosper Menière (Paris, 1799-1862), who first described the symptoms in 1861 and assigned them to the inner ear (with hearing and balance organ).
Personality of the patient Meniere
Because micro-metabolism in the inner ear is very complex and under the influence of the autonomic nervous system, stress and mental stress are repeatedly mentioned as possible contributing or triggering factors. This coincides with the image of the frequently observed personality of the Meniere patient, who is often characterized by a tendency to ambition and perfectionism, namely the risk of putting himself under excessive pressure.
Betahistidine and anticoagulants such as Ginkgoflavonids are often used for the vestibular microcirculation.
For the framework of mental stress can be used mild sedative or sedative or supplements based on the amino acid L-Tryptophan which is metabolized in Serotonin and then in Melatonin. Serotonin has a calming effect and melatonin promotes
Mucolytic Catarrh - Antiedemigenous Rino and Befaroplastica
Serratiopeptidase is the silkworm enzyme that produces with the help of an intestinal bacterium. The caterpillar benefits from this so-called "protease", ie an enzyme that breaks down the enzyme. It allows it to dissolve and fly away from the cocoon in which it is trapped. Serratiopeptidase has many beneficial effects on humans as it removes dead tissue and harmful deposits naturally. Other proteolytic enzyme is Bromelain extracted from the stem of ananas comosus.
Serratiopeptidase and Bromelain has been used successfully in Europe and Asia for over 30 years.
These proteolytic enzymes show effects on several levels:
- the enzyme decomposes bradikinin, which is highly involved in inflammatory reactions. This strong anti-inflammatory effect helps the unpleasant effects of inflammation.
- It acts as fibrinolytic, ie dissolving blood clots.
- Dissolves the mucus, which holds together large amounts of bacteria.
- Unlike conventional painkillers and anti-inflammatory drugs, such as salicylates (aspirin), ibuprofen and steroids (cortisone) do not have long-term side effects.
Positive effects of Serratiopeptidase and Bromelina
- Cardiovascular problems, arteriosclerosis: arteriosclerotic deposits and vein plaques are split by Serratiopeptidase and Bromelina; they help to prevent and reduce varicose veins
- Rheumatoid arthritis: Serratiopeptidase and Bromelain keep the inflammation of the joint under control and reduce the typical discomfort.
- Fibromyalgia: Serratiopeptidase and Bromelain can help reduce pain.
- Cystic fibrosis mastopathy: the chest hardening is dissolved, excessive milk production is prevented
- lung problems, asthma, bronchitis: bronchopulmonary secretolysis and excretions, the persistent mucus is liquefied and can be expectorated, at the same time, the production of mucus is diminished. With the mucous secretions the bacteria contained in it can be removed. But the Serratiopeptidase and Bromelain also attack the biomembranes of the bacteria so that antibiotics and our immune system can destroy the germs more easily
- sinusitis, laryngitis, sore throat, earache: Serratiopeptidase and Bromelain also acts here against phlegm (bacterial) and against inflammation
- Surgery: the pain of the wound disappears faster in the healing process when greenhouse peptidase is administered. The scar is softer due to its anti-fibrosis effect.
- chronic intestinal inflammatory diseases such as Crohn's disease and ulcerative colitis can be improved
- Injury: Serratiopeptidase and Bromelain help against swelling (edema), as it improves vascular permeability and removal of excess water from tissues
- Immunostimulant for recurrent diseases of the respiratory system
Respiratory diseases are among the most common ailments in humans. Basically, it is possible to differentiate upper and lower respiratory tract diseases as well as acute and chronic diseases.
Respiratory diseases are prominently represented in all public health statistics, they are the second most frequent cause of work lost in Germany and the second leading cause of death worldwide. Asthmatic respiratory diseases and COPD, each with about 7 million patients, are among the common diseases in Germany.
Furthermore, respiratory diseases are among the most common diseases. The annual incidence of viral or bacterial pathogens affects almost everyone. Such acute respiratory tract infections spread rapidly and cause flu episodes in the cold season.
Respiratory diseases are inflammatory in most cases. The reason for this is obvious: the respiratory tract is an open system, in which the respiratory tract and pollutants penetrate through breathing in addition to vital oxygen. Therefore, e.g. Dust, smoke, bacteria and viruses in the respiratory tract, where they can cause inflammation.
Some people are born with a genetic defect that causes a particularly hard mucus. These patients suffer from cystic fibrosis.
Respiratory diseases can be substantially differentiated according to the position of the disease. In the upper respiratory tract, it is mainly the different types of sinusitis that are causing problems for many patients.
Sinusitis is an inflammation in the cavities attached to the nose - the paranasal sinuses. Cause are usually bottlenecks in the area of the entrance from the nose to the breasts. They can interrupt the natural flow of the mucus so much that surgery is needed to eliminate bottlenecks.
For permanent inflammatory loads in the upper respiratory tract and a floor change is to be feared. A change in level occurs when an infectious event is transmitted from the upper respiratory tract to the inferior one. Today, this synergistic syndrome is believed to be often involved in the development of chronic inferior respiratory diseases.
In the lower respiratory tract, bronchitis is the most common form of the disease. In the process, the mucous membrane in the bronchial tubes becomes inflamed and the production of mucus increases. The chronic form of bronchitis, which is often found in smokers, carries the risk of switching to COPD or chronic obstructive bronchitis. It is characterized by a progressive narrowing of the respiratory tract.
Acute respiratory tract infections such as bronchitis, sinusitis or rhinitis or their mixed forms are not uncommon. The cold, cough and sore throat are among the typical protagonists of such an acute event, which usually occurs after 1-2 weeks.
However, if there is a constant load, chronic respiratory diseases can also develop. Cigarette consumption, allergies or pollution at work are the most common causes of chronic respiratory events.
The symptomatic therapies used are:
- Mucolytics: such as Acetylcysteine or enzymes such as Serratiopeptidase and bromelain which are also characterized by a marked anti-inflammatory activity.
- Immunostimulants: as plant extracts (eg Echinacea) or some minerals (eg Zinc)
- Antioxidants: such as Vitamin C or lipoic acid